Delivery Order SPE2DB22D3011-SPE2DB25FQ2GE
- Not listed
- The Defense Logistics Agency awarded a $4,484.74 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 60 tablets of Briviact 100 mg, a medication used in the treatment of seizure disorders. This non-set-aside contract, awarded on August 15, 2025, with an ultimate completion date of August 18, 2025, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. As a delivery order, this award represents a task issued under a larger indefinite delivery...
- The Defense Logistics Agency awarded a $2,839.50 delivery order to AmerisourceBergen Drug Corp for Briviact 100 mg tablets (60 units) on August 15, 2025, with an ultimate completion date of August 18, 2025. This contract is structured as a firm fixed price delivery order with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order...
- The Defense Logistics Agency awarded a $2,316.87 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 60-tablet units of Briviact 100 mg, a medication used in the treatment of psychiatric conditions. The contract, awarded on July 18, 2025, with an ultimate completion date of July 21, 2025, represents a non-competitive delivery order under a larger pharmaceutical supply agreement. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Briviact 100mg tablets (60-count packages) at a ceiling value of $3,282.79. This delivery order represents a firm fixed-price contract with no set-aside designation, executed through open competition. The order is scheduled for ultimate completion by August 27, 2025, with performance occurring at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency (DLA) awarded a $1,905.41 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Briviact 25 mg on July 21, 2025, with a completion date of July 22, 2025. This is a firm fixed-price delivery order issued under a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Briviact 75 mg tablets (60-count units) with a ceiling value of $3,651.35. This firm fixed-price delivery order, which is expected to be completed by August 5, 2025, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting the contractor's demonstrated...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Briviact 100 mg tablets in quantities of 60 units, with a ceiling value of $4,082.11. This contract represents a firm fixed price delivery order with an ultimate completion date of August 1, 2025. The award is non-set-aside and was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Briviact 10 mg/mL oral solution in a 300 mL quantity, with a ceiling value of $2,116.72. This competitively awarded, firm fixed-price delivery order is set to be completed by August 13, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $6,443.28 on July 28, 2025, for the supply of Briviact 100 mg tablets in a 60-count package. This is a firm fixed-price delivery order with an ultimate completion date of July 29, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting the contractor's capability to compete in the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for BRIVIACT 25 MG tablets (60-count units) with a ceiling value of $1,053.23. This firm fixed price, non-set-aside delivery order was awarded on July 31, 2025, with an ultimate completion date of August 1, 2025. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- SPE2DB22D3011Indefinite Delivery Contract
- SPE2DB22D3011-SPE2DB25FQ2GEDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 60 tablets of Briviact 75 mg, a medication used in the treatment of seizure disorders. This non-set-aside, competitively awarded contract was executed on August 15, 2025, with a ceiling value of $1,861.04 and a firm fixed price structure. The delivery order is set for completion by August 18, 2025, and will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order functions as a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through December 2026. The parent IDC serves as a comprehensive pharmaceutical support vehicle enabling the company to supply a broad range of medications and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, has demonstrated consistent capability to fulfill federal medical procurement requirements through open competition, delivering diverse pharmaceutical products including specialty medications, generic drugs, and medical supplies across multiple therapeutic domains to the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 8/15/25 |